RECRO PHARMA INC's ticker is REPH and the CUSIP is 75629F109. A total of 70 filers reported holding RECRO PHARMA INC in Q4 2018. The put-call ratio across all filers is - and the average weighting 0.1%.
Links
Filings
- All filings
- Annual reports (10-K)
- Quarterly reports (10-Q)
- Insider transactions
- Shareholder votes
- Significant ownership
- Events
EDGAR links
External links
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $110,000 | -2.7% | 39,500 | 0.0% | 0.00% | – |
| Q4 2020 | $113,000 | +27.0% | 39,500 | -7.1% | 0.00% | – |
| Q3 2020 | $89,000 | -58.4% | 42,500 | -9.6% | 0.00% | – |
| Q2 2020 | $214,000 | -11.9% | 47,000 | +57.7% | 0.00% | – |
| Q1 2020 | $243,000 | -27.2% | 29,800 | +63.7% | 0.00% | – |
| Q4 2019 | $334,000 | +65.3% | 18,200 | 0.0% | 0.00% | – |
| Q3 2019 | $202,000 | +0.5% | 18,200 | -8.1% | 0.00% | – |
| Q2 2019 | $201,000 | +95.1% | 19,800 | +13.1% | 0.00% | – |
| Q1 2019 | $103,000 | -22.6% | 17,500 | -6.4% | 0.00% | – |
| Q4 2018 | $133,000 | 0.0% | 18,700 | 0.0% | 0.00% | – |
| Q3 2018 | $133,000 | +41.5% | 18,700 | 0.0% | 0.00% | – |
| Q2 2018 | $94,000 | – | 18,700 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Samjo Capital LLC | 3,510,000 | $6,318,000 | 5.40% |
| Cowen Prime Advisors LLC | 4,162,500 | $7,493,000 | 3.15% |
| Athyrium Capital Management, LP | 2,202,420 | $3,964,000 | 1.41% |
| AWM Investment Company, Inc. | 5,081,901 | $9,147,000 | 1.18% |
| Parkman Healthcare Partners LLC | 671,817 | $1,209,000 | 0.35% |
| ESSEX INVESTMENT MANAGEMENT CO LLC | 799,841 | $1,440,000 | 0.18% |
| Rubric Capital Management LP | 1,076,587 | $1,938,000 | 0.07% |
| TITLEIST CAPITAL, LLC | 180,093 | $324,000 | 0.06% |
| Clear Harbor Asset Management, LLC | 266,972 | $481,000 | 0.06% |
| Frontier Wealth Management LLC | 64,605 | $2,701,000 | 0.03% |